Uflex Ltd

- No explicit mention of any new fundraising through debt or equity during the call. - The company is nearing the completion of major capex projects, including: - 12 billion packs expansion of aseptic liquid packaging in Egypt. - Recycling plant in India. - Woven polypropylene bag production capacity in Mexico. - Current capex requirements are around Rs. 110-120 crore for the recycling plant and BOPP Dharwad plant. - Debt levels are expected to be largely steady, with repayments and remaining capex roughly offsetting each other. - Management indicates the debt leverage has peaked and will improve as EBITDA grows; no plans for significant new debt. - Focus is on improving EBITDA and managing existing leverage rather than raising fresh funds.

- Remaining capex of about Rs. 110-120 crore for the recycling plant at Noida. - Remaining capex for the BOPP Dharwad plant. - Residual capex largely to be spent over the next 1 year; total capex around Rs. 1,200 crore for next financial year. - Around Rs. 350 crore capex remaining post Q3 for the Egypt aseptic plant. - Three major projects near commissioning: - 12 billion packs expansion of aseptic liquid packaging in Egypt. - 40,000 tons recycling plant in India near commissioning. - 80 billion bags polypropylene woven bag plant in Mexico. - Strategic investment focus on high-barrier, metallized, value-added films in evolved markets like the US. - Investment aligned to growth plans; expected to maintain debt levels while leveraging improved EBITDA to manage leverage ratio.

- Aseptic packaging volumes expected around 8.5 billion packs in FY26, with potential upside (Page 5, 9). - Significant improvement in volumes anticipated from FY27 onwards after commissioning new Egypt aseptic plant and full utilization of expanded India facility (Page 9). - Incremental revenue from three new projects expected to be Rs. 2,000-2,500 crore at high-teens margin/full capacity (Page 13). - Liquid packaging business expected to grow exponentially, consolidating market share in India and catering export demand through Egypt plant (Page 18). - Top-line growth guidance for FY26 is around 5%, with EBITDA expected Rs. 1,800-1,850 crore, and margin to improve beyond 12% in FY27 due to better product mix and price realizations (Pages 16, 24). - Packaging films and flexible packaging segments showing signs of recovery with better demand and pricing expected in Q4 and beyond (Pages 13, 18). Overall, growth is driven by capacity expansions, market leadership consolidation, and improved product mix.

- EBITDA for FY'26 is expected to be around Rs. 1,800 to Rs. 1,850 crore, with margins near 12%, supported by improved Q4 performance. - Incremental revenue of Rs. 2,000 to Rs. 2,500 crore expected from three new plants at full capacity, with margins in high teens to around 20%. - FY'27 margins anticipated to improve further beyond 12% due to better product mix, cost rationalization, and price realization. - EPS for Q3 FY26 stood at Rs. 5.01, with profits showing sequential growth; PAT up 34% quarter-on-quarter. - Growth drivers include expansion in aseptic packaging (expected 8.5 billion packs sales in FY27), rising demand in India and overseas markets, and strategic investments in recycling and value-added films. - Leverage ratio likely to improve due to EBITDA growth, even if debt levels do not significantly reduce immediately.

The transcript from the Q3 and 9M FY26 Earnings Conference Call on February 16, 2026, does not explicitly mention the current or expected order book or pending orders for UFlex Limited. The discussion primarily revolves around: - Capacity utilization across different plants and geographies. - Commissioning timelines for upcoming projects like the aseptic packaging plant in Egypt, recycling plant in Noida, and WPP plant in Mexico. - Market demand trends for packaging films (BOPET, BOPP). - Debt levels and financial guidance. - Suggestions for promoter involvement in earnings calls. No direct information on order book status or pending orders is provided in the provided pages.